Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

被引：0
作者：
Michael Dieckmeyer
Stefan Ruschke
Alexander Rohrmeier
Jan Syväri
Ingo Einspieler
Vanadin Seifert-Klauss
Monika Schmidmayr
Stephan Metz
Jan S. Kirschke
Ernst J. Rummeny
Claus Zimmer
Dimitrios C. Karampinos
Thomas Baum
机构：
[1] Technische Universität München,Department of Diagnostic and Interventional Neuroadiology, Klinikum rechts der Isar
[2] Technische Universität München,Department of Radiology, Klinikum rechts der Isar
[3] University Medical Center Regensburg,Department of Radiology
[4] Technische Universität München,Department of Gynecology and Obstetrics, Klinikum rechts der Isar
来源：
BMC Musculoskeletal Disorders | / 20卷
关键词：
Osteoporosis; Bisphosphonates; Aromatase inhibitor; Vertebral bone marrow; Proton density fat fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Chemical Shift-Encoded MRI of the Lumbar Vertebral Bone Marrow for Detecting Osteoporosis With Low Trabecular Bone Quality in Patients With Breast Cancer Receiving Aromatase Inhibitors [J].
Misaka, Tomofumi ;
Hashimoto, Yukihiko ;
Ashikaga, Ryuichiro ;
Ishida, Takayuki .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 60 (04) :1379-1389
[22]   The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women [J].
Mouridsen, HT ;
Robert, NJ .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) :1678-1689
[23]   IBISII: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole [J].
Cuzick, Jack .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) :1377-1385
[24]   Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis [J].
Chen, Shanshan ;
Bo, Lan ;
Lv, Dan ;
Ma, Fei .
BREAST CARE, 2022, 17 (04) :391-402
[25]   Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors [J].
Ogata, Nanae ;
Toh, Uhi ;
Sudou, Tomoya ;
Ogata, Suguru ;
Takao, Yuko ;
Sugihara, Rie ;
Watanabe, Hideaki ;
Matushima, Shuntaro ;
Akagi, Yoshito .
ANTICANCER RESEARCH, 2022, 42 (08) :4139-4143
[26]   Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole [J].
Sun, Shengliang ;
Wang, Fuchao ;
Dou, Honglei ;
Zhang, Longqiang ;
Li, Jiwen .
ONCOTARGETS AND THERAPY, 2016, 9 :6029-6036
[27]   Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy [J].
Gentry, Amanda L. ;
Erickson, Kirk I. ;
Sereika, Susan M. ;
Casillo, Frances E. ;
Crisafio, Mary E. ;
Donahue, Patrick T. ;
Grove, George A. ;
Marsland, Anna L. ;
Watt, Jennifer C. ;
Bender, Catherine M. .
CONTEMPORARY CLINICAL TRIALS, 2018, 67 :109-115
[28]   Review of bone health in women receiving endocrine therapy because of breast cancer [J].
Kollar, Reka ;
Leel-Ossy, Tamas ;
Palffy, Veronika ;
Dank, Magdolna ;
Horvath, Csaba ;
Meszaros, Szilvia .
ORVOSI HETILAP, 2024, 165 (21) :813-821
[29]   Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors [J].
Mincey, Betty A. ;
Duh, Mei Sheng ;
Thomas, Simu K. ;
Moyneur, Erick ;
Marynchencko, Maryna ;
Boyce, Simone Peart ;
Mallett, David ;
Perez, Edith A. .
CLINICAL BREAST CANCER, 2006, 7 (02) :127-132
[30]   Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial [J].
Kilbreath, Sharon ;
Refshauge, Kathryn M. ;
Beith, Jane ;
Ward, Leigh ;
Sawkins, Kate ;
Paterson, Ross ;
Clifton-Bligh, Philip ;
Sambrook, Philip N. ;
Simpson, Judy M. ;
Nery, Liza .
CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) :704-709
12345